1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015

Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015" provides data on the Ileus (Intestinal Obstruction) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ileus (Intestinal Obstruction) . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ileus (Intestinal Obstruction) . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Ileus (Intestinal Obstruction) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Ileus (Intestinal Obstruction) 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Ileus (Intestinal Obstruction) Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Tsumura and co. 31
Clinical Trial Overview of Tsumura and co. 31
Valeant Pharmaceuticals International, Inc. 33
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 33
Merck and Co., Inc. 34
Clinical Trial Overview of Merck and Co., Inc. 34
Norgine B.V. 35
Clinical Trial Overview of Norgine B.V. 35
Ipsen S.A. 36
Clinical Trial Overview of Ipsen S.A. 36
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Ocera Therapeutics, Inc. 39
Clinical Trial Overview of Ocera Therapeutics, Inc. 39
Cato Research Ltd. 40
Clinical Trial Overview of Cato Research Ltd. 40
Botanic Century 41
Clinical Trial Overview of Botanic Century 41
Clinical Trial Overview of Top Institutes / Government 42
Japanese Foundation for Cancer Research 42
Clinical Trial Overview of Japanese Foundation for Cancer Research 42
Chiang Mai University 43
Clinical Trial Overview of Chiang Mai University 43
Nanjing PLA General Hospital 44
Clinical Trial Overview of Nanjing PLA General Hospital 44
Queen's University 45
Clinical Trial Overview of Queen's University 45
University Medicine Greifswald 46
Clinical Trial Overview of University Medicine Greifswald 46
Wakayama Medical University 47
Clinical Trial Overview of Wakayama Medical University 47
Academic Medical Center 48
Clinical Trial Overview of Academic Medical Center 48
Atrium Medical Center 49
Clinical Trial Overview of Atrium Medical Center 49
Azienda Ospedaliera Universitaria Policlinico catania 50
Clinical Trial Overview of Azienda Ospedaliera Universitaria Policlinico catania 50
Baqiyatallah Medical Sciences University 51
Clinical Trial Overview of Baqiyatallah Medical Sciences University 51
Five Key Clinical Profiles 52
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 80

List of Tables
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Ileus (Intestinal Obstruction) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Ileus (Intestinal Obstruction) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Ileus (Intestinal Obstruction) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Ileus (Intestinal Obstruction) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Ileus (Intestinal Obstruction) Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Ileus (Intestinal Obstruction) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tsumura and co., 2015* 31
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 33
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 34
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Norgine B.V., 2015* 35
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2015* 36
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 37
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 38
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocera Therapeutics, Inc., 2015* 39
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cato Research Ltd., 2015* 40
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Botanic Century, 2015* 41
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Foundation for Cancer Research, 2015* 42
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiang Mai University, 2015* 43
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing PLA General Hospital, 2015* 44
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2015* 45
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medicine Greifswald, 2015* 46
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Wakayama Medical University, 2015* 47
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 48
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Atrium Medical Center, 2015* 49
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria Policlinico catania, 2015* 50
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baqiyatallah Medical Sciences University, 2015* 51

List of Figures
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Ileus (Intestinal Obstruction) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Ileus (Intestinal Obstruction) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Ileus (Intestinal Obstruction) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Ileus (Intestinal Obstruction) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Ileus (Intestinal Obstruction) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.